CimaVax-EGF, the first therapeutic cancer vaccine developed to target lung cancer.
•
Stimuvax, which had promising results from a phase IIB trial for inoperable lung cancer.
cancer | American Cancer Society | breast cancer | National Cancer Institute | Cancer Research UK | Cancer | vaccine | Memorial Sloan-Kettering Cancer Center | MMR vaccine | Hau Lung-pin | Fred Hutchinson Cancer Research Center | colorectal cancer | Tropic of Cancer | prostate cancer | National Heart, Lung, and Blood Institute | Macmillan Cancer Support | lung | Ludwig Institute for Cancer Research | liver cancer | Fox Chase Cancer Center | Colorectal cancer | American Lung Association | Teenage Cancer Trust | Princess Margaret Cancer Centre | International Agency for Research on Cancer | Esophageal cancer | Breast Cancer Care | Breast Cancer | Vaccine | Union for International Cancer Control |